drugset / Trial / NCT01192971
A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
Phase 2
Completed
121 enrolled
Jiangsu HengRui Medicine Co., Ltd.
Eighty-One Hospital of People's Liberation Army · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This phase II trial will be studying how well Apatinib working in patients with Hepatocellular carcinoma.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 750 mg | Oral |
| Subject | Rivoceranib | Small molecule | 850 mg | Oral |